首页|丹蛭降糖胶囊联合多格列艾汀治疗气阴两虚型2型糖尿病临床观察

丹蛭降糖胶囊联合多格列艾汀治疗气阴两虚型2型糖尿病临床观察

Clinical observation of Danzhi Jiangtang Capsules combined with dorzagliatin in treating type 2 diabetes mellitus with Qi-Yin deficiency syndrome

扫码查看
目的:观察丹蛭降糖胶囊联合多格列艾汀治疗气阴两虚型2型糖尿病的疗效及安全性.方法:选取2022年11月1日—2022年12月31日就诊于安徽中医药大学第一附属医院内分泌科门诊的30名2型糖尿病患者,随机分为治疗组与对照组,每组15例.在降脂、降压等对症治疗的基础上,对照组给予多格列艾汀口服,75 mg/次,2次/d;治疗组在对照组治疗基础上加丹蛭降糖胶囊口服,2.0 g/次,3次/d.两组均连续治疗12周.观察两组患者空腹血糖(FPG)、餐后2 h血糖(2 hPG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)水平的变化,计算胰岛素抵抗指数(HOME-IR)、胰岛素敏感指数(ISI),对中医临床疗效进行评估;并监测患者谷丙转氨酶(ALT)、谷草转氨酶(AST)、血尿素氮(BUN)、血肌酐(Scr)水平及不良反应.结果:与治疗前比较,治疗后两组患者FPG、2 hPG、HbA1c、FINS、HOME-IR均降低,ISI升高,差异均有统计学意义(P<0.01).治疗后治疗组患者FPG、2 hPG、HbAlc低于对照组,总有效率高于对照组,差异有统计学意义(P<0.05,P<0.01).治疗后两组患者均未出现不良反应.结论:丹蛭降糖胶囊联合多格列艾汀治疗气阴两虚型2型糖尿病能够有效控制患者的血糖水平,并促进胰岛功能恢复,改善临床症状,安全性较好.
Objective:To observe the efficacy and safety of Danzhi Jiangtang Capsules combined with dorzagliatin in treating type 2 diabetes mellitus with Qi-Yin deficiency syndrome.Methods:Thirty type 2 diabetes mellitus patients who visited the Endocrinology Department of the First Affiliated Hospital of Anhui University of Chinese Medicine between No-vember 1,2022,and December 31,2022,were randomly divided into a treatment group and a control group,with 15 pa-tients in each group.On the basis of symptomatic treatments such as lipid-lowering and blood pressure-lowering,patients in the control group received oral administration of dorzagliatin at 75 mg per dose,twice daily.The patients in the treatment group were treated with Danzhi Jiangtang Capsules orally,2.0 g/time,3 times/d on the basis of the treatment of the control group.Both groups were treated for 12 weeks.Changes in fasting plasma glucose(FPG),2-hour postprandial glucose(2 hPG),glycosylated hemoglobin(HbA1c),and fasting insulin(FINS)levels of the patients in the two groups were observed,and homeostatic model assessment of insulin resistance(HOMA-IR),and insulin sensitivity index(ISI)were calculated to evaluate the clinical efficacy of traditional Chinese medicine.The levels of alanine aminotransferase(ALT),aspartate ami-notransferase(AST),blood urea nitrogen(BUN),serum creatinine(Scr)and adverse reactions were monitored.Results:Compared with those before treatment,FPG,2 hPG,HbA1c,FINS and HOME-IR were decreased and ISI was increased in both groups after treatment,and the differences were statistically significant(P<0.01).After treatment,FPG,2 hPG and HbAlc of patients in the treatment group were lower than those in the control group,and the total effective rate was higher than that of the control group,and the difference was statistically significant(P<0.05,P<0.01).No adverse reactions oc-curred in both groups after treatment.Conclusion:Danzhi Jiangtang Capsules combined with dorzagliatin can effectively control blood glucose levels in patients with type 2 diabetes mellitus with Qi-Yin deficiency syndrome,promote pancreatic function recovery,improve clinical symptoms,and demonstrate a better safety.

type 2 diabetes mellitusDanzhi Jiangtang Capsulesdorzagliatinclinical observation

毕正、张银玉、吕溪娟、张文锦、方朝晖

展开 >

安徽中医药大学,安徽 合肥 230038

安徽中医药大学第一附属医院,安徽 合肥 230031

2型糖尿病 丹蛭降糖胶囊 多格列艾汀 临床观察

2024

山西中医药大学学报

山西中医药大学学报

ISSN:
年,卷(期):2024.25(11)